MedTrace Logo

The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients

NCT00247507 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2006-10-18

No results posted yet for this study

Summary

The aim of this study is to explore and identify the effects of acetylcysteine, a common mucolytic with anti-oxidant property, on alleviating the damage caused by increased oxidative stress in hemodialysis patients.

Conditions

Interventions

DRUG

acetylcysteine

Sponsors & Collaborators

  • Far Eastern Memorial Hospital

    lead OTHER

Principal Investigators

  • Shih-Ping Hsu, M.D. · Far Eastern Memorial Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Completion
2005-12-31

Countries

  • Taiwan

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00247507 on ClinicalTrials.gov